Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Study of Irinotecan and Whole Brain Radiation Therapy in Patients With Brain Metastases From Solid Tumors

NCT00389584 is registered in ClinicalTrials.gov with University of California, Davis as lead sponsor.

NCT NCT00389584
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00389584 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Study of Irinotecan and Whole Brain Radiation Therapy in Patients With Brain Metastases From Solid Tumors
Lead sponsor
University of California, Davis
Phase
Phase 1/2
Overall status
Completed
Start date
December 31, 2002
Completion date
November 30, 2006
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain and central nervous system tumors, cognitive/functional effects, long-term effects secondary to cancer therapy in adults, long-term effects secondary to cancer therapy in children, poor performance status, unspecified adult solid tumor, protocol specific, unspecified childhood solid tumor, protocol specific